dhfr and dhps genotype and sulfadoxine-pyrimethamine treatment failure in children with falciparum malaria in the Democratic Republic of Congo.
dhfr and dhps genotype and sulfadoxine-pyrimethamine treatment failure in children with falciparum malaria in the Democratic Republic of Congo.
复制标题
DOI：
10.1111/j.1365-3156.2008.02150.x
复制
发表时间：
2008-11
期刊：
影响因子：
--
通讯作者：
Meshnick SR
中科院分区：
文献类型：
--
作者：
Alker AP;Kazadi WM;Kutelemeni AK;Bloland PB;Tshefu AK;Meshnick SR
To determine the relationship between mutations in dhfr and dhps and SP treatment failure in Plasmodium falciparum malaria in the Democratic Republic of the Congo (DRC) Between June and September 2002, a therapeutic efficacy trial was conducted in Rutshuru, Eastern DRC, comparing sulfadoxine-pyrimethamine (SP), SP plus amodiaquine (AQSP), and artesunate plus SP (ASSP) regimens for treating malaria in children under 5 years old. We genotyped 212 samples for mutations associated with SP resistance and investigated their association with treatment failure. In the SP arm, 61% of the subjects experienced treatment failure after 14 days. The failure rate was lower in the combination arms (AQSP: 32%, ASSP: 21%). The dhfr-108 and dhfr-51 mutations were nearly universal while 89% of the samples had at least one additional mutation at dhfr-59, dhps-437, or dhps-540. Dhps mutations had a bigger impact on treatment failure in children with high parasite density: for children with a parasite density less than 45,000 parasites/μl, the risk of treatment failure was 37% for mutations at dhps-437 and dhps-540 mutation and 21% for neither mutation (risk difference (RD) = 17%, 95%CI: −3%, 36%). In children with a parasite density greater than 45,000 parasites/μl, the treatment failure risk was 58% and 8% for children with both mutations or neither mutation, respectively (RD = 51%, 95%CI: 34%, 67%). Dhps-437 and dhps-540 are strongly associated with SP treatment failure and should be evaluated further as a method for surveillance of SP-based therapy in the DRC.
登录
查看更多内容
影响因子：
3.3
作者：
Anderson, TJC;Nair, S;Balkan, S
通讯作者：
Balkan, S
影响因子：
3.2
作者：
Talisuna, Ambrose O.;Nalunkuma-Kazibwe, Anne;D'Alessandro, Umberto
通讯作者：
D'Alessandro, Umberto
影响因子：
--
作者：
Khalil, IF;Alifrangis, M;Bygbjerg, IC
通讯作者：
Bygbjerg, IC
DOI：
10.1016/s0035-9203(01)90250-0
发表时间：
2001-05-01
影响因子：
2.2
作者：
Omar, SA;Adagu, IS;Warhurst, DC
通讯作者：
Warhurst, DC
影响因子：
5
作者：
ROTHMAN, KJ;GREENLAND, S;WALKER, AM
通讯作者：
WALKER, AM